Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12842131rdf:typepubmed:Citationlld:pubmed
pubmed-article:12842131lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0085828lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0002600lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0107103lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C1148673lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C2266866lld:lifeskim
pubmed-article:12842131lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:12842131pubmed:issue2lld:pubmed
pubmed-article:12842131pubmed:dateCreated2003-7-4lld:pubmed
pubmed-article:12842131pubmed:abstractTextThe present study was undertaken to examine the effects of the antidepressant, amitriptyline, and brain-derived neurotrophic factor (BDNF) on activator protein-1 (AP-1) DNA binding activity in the rat brain. Acute administration of amitriptyline (5 or 10 mg/kg) initially increased but then decreased AP-1 DNA binding activity in the rat frontal cortex and hippocampus. Chronic administration of amitriptyline (5 or 10 mg/kg, once daily for 3 weeks) initially decreased AP-1 DNA binding activity but ultimately resulted in its persistent elevation in the rat frontal cortex. In contrast, the chronic administration of amitriptyline did not affect the low activity of AP-1 DNA binding in the hippocampus. However, chronic administration of amitriptyline (10 mg/kg, once daily for 3 weeks) significantly increased BDNF protein levels in the hippocampus (by 26.9%) and frontal cortex (by 24.6%). Direct infusion of BDNF (1 microg) into the hippocampal dentate gyrus significantly increased hippocampal AP-1 DNA binding activity. These results suggest that AP-1 transcription factor may be modulated by BDNF and that it may be an important target for the action of antidepressants.lld:pubmed
pubmed-article:12842131pubmed:languageenglld:pubmed
pubmed-article:12842131pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12842131pubmed:citationSubsetIMlld:pubmed
pubmed-article:12842131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12842131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12842131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12842131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12842131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12842131pubmed:statusMEDLINElld:pubmed
pubmed-article:12842131pubmed:monthAuglld:pubmed
pubmed-article:12842131pubmed:issn0028-3908lld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:OkamotoHHlld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:HashimotoKKlld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:ShirasawaHHlld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:ShimizuEElld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:ShineGGlld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:LuN MNMlld:pubmed
pubmed-article:12842131pubmed:authorpubmed-author:KumakiriCClld:pubmed
pubmed-article:12842131pubmed:issnTypePrintlld:pubmed
pubmed-article:12842131pubmed:volume45lld:pubmed
pubmed-article:12842131pubmed:ownerNLMlld:pubmed
pubmed-article:12842131pubmed:authorsCompleteYlld:pubmed
pubmed-article:12842131pubmed:pagination251-9lld:pubmed
pubmed-article:12842131pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:meshHeadingpubmed-meshheading:12842131...lld:pubmed
pubmed-article:12842131pubmed:year2003lld:pubmed
pubmed-article:12842131pubmed:articleTitleDynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor.lld:pubmed
pubmed-article:12842131pubmed:affiliationDepartment of Psychiatry, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba 260-8677, Japan. okamo@med.teikyo-u.ac.jplld:pubmed
pubmed-article:12842131pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12842131lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12842131lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12842131lld:pubmed